PRVA Stock Overview
Operates as a national physician-enablement company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
Privia Health Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$23.68 |
| 52 Week High | US$26.04 |
| 52 Week Low | US$15.92 |
| Beta | 0.88 |
| 1 Month Change | 0.25% |
| 3 Month Change | 6.47% |
| 1 Year Change | 32.88% |
| 3 Year Change | -9.58% |
| 5 Year Change | n/a |
| Change since IPO | -31.86% |
Recent News & Updates
Recent updates
Is There An Opportunity With Privia Health Group, Inc.'s (NASDAQ:PRVA) 48% Undervaluation?
Feb 05
After Leaping 32% Privia Health Group, Inc. (NASDAQ:PRVA) Shares Are Not Flying Under The Radar
Nov 08There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital
Nov 04It's A Story Of Risk Vs Reward With Privia Health Group, Inc. (NASDAQ:PRVA)
Sep 12
Tactical Expansions And Value-Based Care Drive Optimistic Growth In Healthcare Sector
Sep 10 Privia Health's strategy focuses on market penetration and provider network expansion to fuel revenue growth, alongside restructuring contracts for better margins.There May Be Reason For Hope In Privia Health Group's (NASDAQ:PRVA) Disappointing Earnings
Aug 16Some Investors May Be Worried About Privia Health Group's (NASDAQ:PRVA) Returns On Capital
Jul 12Privia Health Group, Inc.'s (NASDAQ:PRVA) Subdued P/S Might Signal An Opportunity
Jun 11Privia Health: Key Lessons Learned (Rating Downgrade)
May 22Analysts Just Slashed Their Privia Health Group, Inc. (NASDAQ:PRVA) EPS Numbers
Mar 03The Price Is Right For Privia Health Group, Inc. (NASDAQ:PRVA)
Feb 27There Are Reasons To Feel Uneasy About Privia Health Group's (NASDAQ:PRVA) Returns On Capital
Jan 31Why Privia Health Group, Inc. (NASDAQ:PRVA) Could Be Worth Watching
Dec 03Privia Health Group, Inc.'s (NASDAQ:PRVA) Price In Tune With Revenues
Nov 06Privia Health Group's (NASDAQ:PRVA) Returns On Capital Not Reflecting Well On The Business
Aug 08Privia Health Group, Inc. (NASDAQ:PRVA) Shares Could Be 48% Below Their Intrinsic Value Estimate
Mar 17Privia Health: In Line For Solid FY22, Hold On Valuation
Sep 15Privia Health Group reports Q2 earnings beat; raises FY22 outlook
Aug 11Shareholder Returns
| PRVA | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0.1% | -0.06% | -3.0% |
| 1Y | 32.9% | 7.6% | 4.6% |
Return vs Industry: PRVA exceeded the US Healthcare industry which returned 7.6% over the past year.
Return vs Market: PRVA exceeded the US Market which returned 4.6% over the past year.
Price Volatility
| PRVA volatility | |
|---|---|
| PRVA Average Weekly Movement | 4.9% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 7.7% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 4.0% |
Stable Share Price: PRVA has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: PRVA's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 1,140 | Parth Mehrotra | www.priviahealth.com |
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It offers technology and population health tools to enhance providers’ workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives.
Privia Health Group, Inc. Fundamentals Summary
| PRVA fundamental statistics | |
|---|---|
| Market cap | US$2.88b |
| Earnings (TTM) | US$14.39m |
| Revenue (TTM) | US$1.74b |
198.4x
P/E Ratio1.6x
P/S RatioIs PRVA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRVA income statement (TTM) | |
|---|---|
| Revenue | US$1.74b |
| Cost of Revenue | US$1.56b |
| Gross Profit | US$176.85m |
| Other Expenses | US$162.47m |
| Earnings | US$14.39m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 08, 2025
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 10.19% |
| Net Profit Margin | 0.83% |
| Debt/Equity Ratio | 0% |
How did PRVA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/17 21:38 |
| End of Day Share Price | 2025/04/17 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Privia Health Group, Inc. is covered by 33 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hua Ha | Baird |
| Andrew Mok | Barclays |
| Adam Ron | BofA Global Research |